Skip to content
PubMed This is a summary of 36 peer-reviewed journal articles Updated
Neurology

Megalencephalic leukoencephalopathy with subcortical cysts (MLC): A Patient Guide

At a Glance

MLC is a rare genetic disorder of the brain’s white matter that often causes a large head size in infancy, followed by a variable course. MRI and genetic testing help identify the form, while long-term multidisciplinary care supports movement, development, seizure management, and quality of life.

Receiving a diagnosis of Megalencephalic leukoencephalopathy with subcortical cysts (MLC) for your child is the beginning of a complex journey, but you do not have to navigate it without a map. This rare genetic leukodystrophy primarily affects the brain’s white matter, the specialized tissue that serves as the communication wiring for the body. While the name of the condition is daunting, understanding its biology helps demystify the symptoms you see. At its core, MLC involves a disruption in how brain cells manage fluid and salt, leading to characteristic swelling and the formation of small fluid-filled pockets called subcortical cysts [1].

The hallmark of MLC is macrocephaly, or an unusually large head size, which typically becomes noticeable in infancy or early childhood. For many families, this early period is often a time of typical or near-typical developmental progress, as children often reach early milestones like sitting and smiling on a standard schedule [2]. This “early window” of stability is a defining feature of the condition, though it eventually gives way to a slow, gradual decline in motor skills, such as balance and coordination, in the more common Classic form of the disease. In contrast, the Remitting form (MLC2B) may see an improvement in brain swelling over time, though it requires its own unique focus on developmental and cognitive support [3].

Please note that the clinical course of MLC varies widely. The subtypes and genotypes require specialist interpretation, and this guide is not a substitute for the guidance of your child’s neurologist or genetic counselor.

Living with MLC is centered on preserving your child’s quality of life and maximizing their independence. Because the condition progresses slowly—often over decades—care is built around a “multidisciplinary” approach that addresses the physical, neurological, and developmental needs of your child as they grow. Maintaining motor function, such as the ability to walk and play, is often the highest priority, supported by a dedicated team of therapists and neurologists who work together to manage symptoms like muscle stiffness or seizures [4].

This guide is designed to empower you with evidence-based information to help you manage your child’s care with confidence. It provides a deep dive into the biological and genetic roots of the condition, explains the critical role of MRI and genetic testing in confirming a diagnosis, and outlines the standard of care for symptom management. You will also find practical guidance on building a specialized medical team and identifying the “red flags” that require urgent attention. By understanding the “why” behind your child’s symptoms, you can better advocate for the “how” of their care, ensuring they receive the support they need at every stage [5].

Common questions in this guide

What is MLC and what part of the brain does it affect?
MLC is a rare genetic leukodystrophy, a condition that affects the brain’s white matter. Problems with how brain cells manage fluid and salt can lead to swelling and characteristic fluid-filled pockets called subcortical cysts.
What are the first signs of MLC in a child?
An unusually large head, called macrocephaly, often becomes noticeable in infancy or early childhood. Children may reach early milestones on a typical or near-typical schedule before motor skills such as balance and coordination gradually become more difficult, especially in Classic MLC.
How do doctors confirm an MLC diagnosis?
Doctors use brain MRI to look for characteristic white-matter changes, swelling, and subcortical cysts, together with genetic testing. A neurologist or genetics specialist interprets these findings to identify the child’s form of MLC.
What is the difference between Classic MLC and Remitting MLC?
In Classic MLC, early development may be near typical, followed by slow decline in motor skills such as balance and coordination. In Remitting MLC, also called MLC2B, brain swelling may improve over time, but children still need developmental and cognitive support.
What treatments and support does a child with MLC need?
Care is usually multidisciplinary and focuses on preserving movement, independence, and quality of life. Neurologists and therapists help manage problems such as muscle stiffness and seizures while supporting developmental and cognitive needs.
How should families monitor changes in seizures or balance?
Families should work with the child’s neurologist to create a plan for watching for new seizures, changes in balance, or other motor changes. Report new or worsening symptoms promptly and ask which signs require urgent attention.
Does MLC progress the same way in every child?
No. The course varies widely by form and genetic subtype; the Classic form may progress slowly over decades, while the Remitting form may show improvement in brain swelling. Specialists use MRI, genetic findings, and clinical follow-up to interpret the expected course.

Get notified when new evidence is published on Megalencephalic leukoencephalopathy with subcortical cysts.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (5)
  1. 1

    Megalencephalic leukoencephalopathy with subcortical cysts: a variant update and review of the literature.

    Passchier EMJ, Bisseling Q, Helman G, et al.

    Frontiers in genetics 2024; (15()):1352947 doi:10.3389/fgene.2024.1352947.

    PMID: 38487253
  2. 2

    Megalencephalic leucoencephalopathy with subcortical cysts: subcortical diffuse leucoencephalopathy associated with white matter cystic degeneration.

    Dash PK, Raj DH, Sahu H

    BMJ case reports 2015; (2015()).

    PMID: 26392452
  3. 3

    Megalencephalic leukoencephalopathy with subcortical cysts: Characterization of disease variants.

    Hamilton EMC, Tekturk P, Cialdella F, et al.

    Neurology 2018; (90(16)):e1395-e1403 doi:10.1212/WNL.0000000000005334.

    PMID: 29661901
  4. 4

    Megalencephalic leukoencephalopathy with subcortical cysts: a multicenter Italian experience.

    Sartorelli J, Tonduti D, Ambrosini E, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(1)):66 doi:10.1007/s10072-025-08610-z.

    PMID: 41483250
  5. 5

    Patient and Family Perspectives on Clinical Outcomes in Therapy Trials in Megalencephalic Leukoencephalopathy with Subcortical Cysts: An Open Inventory.

    Versaevel NRA, Chapleau A, Topaloğlu P, et al.

    Neuropediatrics 2026; (57(3)):186-192 doi:10.1055/a-2851-9956.

    PMID: 42025183

This page is for educational purposes only and does not constitute medical advice. Your child’s neurologist, genetic counselor, and wider care team should interpret MRI and genetic results and tailor monitoring and treatment to your child.